VML Birdwatching at the Loeries | The Loeries a great stage for SAT
Danette Breitenbach
VML Birdwatching at the Loeries | The future is now, AI is now!
Danette Breitenbach
Trending
Advertise your job vacancies
Subscribe & Follow
Jobs
- Lecturer Cape Town
- Lecturer Cape Town
- Sports Partnership Account Manager Johannesburg
- Media Data Analyst Johannesburg
- Multimedia Designers Cape Town
- Aftersales & Sales Administrative Assistant Cape Town
- FMCG Junior Key Account Manager Cape Town
- Receptionist Cape Town
- Multimedia and Content Designer Johannesburg
- Senior Sales Manager Johannesburg
Nestlé to acquire biopharmaceutical company Aimmune
Nestlé Health Science (NHSc) is to acquire Aimmune Therapeutics in accordance with a definitive agreement between Nestlé and the biopharmaceutical company.
NHSc currently has a total investment in Aimmune of $473m, an approximate 25.6% equity ownership stake. The company made its initial investment of $145m in Aimmune in November 2016, followed by further investments of $30m in February 2018, $98m in November 2018 and $200m in January 2020.
